Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate and Attention Process Training for attention deficits after traumatic brain injury
ACTRN12612000484842Phase 4Terminated
- Sponsor
- Monash University
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in traumatic brain injury (TBI) (5 arms), sponsored by Monash University. Primary endpoints: Performance on standard cognitive measures, Rating Scale of Attentional Behaviour and 1 more. Started Aug 2012; status: terminated.
02
Drugs
methylphenidate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ACTRN12612000484842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000484842.